These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37081108)
1. Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling. Shen L; Li Y; Hu G; Song X; Wang X; Li X; Xu X Funct Integr Genomics; 2023 Apr; 23(2):133. PubMed ID: 37081108 [TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903 [TBL] [Abstract][Full Text] [Related]
3. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression. Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827 [TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway. Min L; Wang H; Qi H Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920 [TBL] [Abstract][Full Text] [Related]
5. M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway. Liu CY; Xu JY; Shi XY; Huang W; Ruan TY; Xie P; Ding JL Lab Invest; 2013 Jul; 93(7):844-54. PubMed ID: 23752129 [TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis. Wang X; Gao S; Song L; Liu M; Sun Z; Liu J Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900 [TBL] [Abstract][Full Text] [Related]
7. M2 macrophages induce EMT through the TGF-β/Smad2 signaling pathway. Zhu L; Fu X; Chen X; Han X; Dong P Cell Biol Int; 2017 Sep; 41(9):960-968. PubMed ID: 28493530 [TBL] [Abstract][Full Text] [Related]
8. Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway. Cai J; Xia L; Li J; Ni S; Song H; Wu X Cancer Res Treat; 2019 Jan; 51(1):252-266. PubMed ID: 29690747 [TBL] [Abstract][Full Text] [Related]
9. Ionizing Radiation Promotes Epithelial-to-Mesenchymal Transition in Lung Epithelial Cells by TGF-β-producing M2 Macrophages. Park HR; Jo SK; Jung U In Vivo; 2019; 33(6):1773-1784. PubMed ID: 31662502 [TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling. Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860 [TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/Foxo1 pathway. Yu Y; Hao J; Wang L; Zheng X; Xie C; Liu H; Wu J; Qiao S; Shi J Pathol Res Pract; 2023 Sep; 249():154766. PubMed ID: 37633006 [TBL] [Abstract][Full Text] [Related]
12. Leucine rich α2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes. Wang D; Pei W; Liu Y; Mo R; Li X; Gu W; Su Y; Ye J; Xu J; Zhao D Exp Lung Res; 2024; 50(1):136-145. PubMed ID: 39033404 [No Abstract] [Full Text] [Related]
13. Dihydroartemisinin Prevents Progression and Metastasis of Head and Neck Squamous Cell Carcinoma by Inhibiting Polarization of Macrophages in Tumor Microenvironment. Chen R; Lu X; Li Z; Sun Y; He Z; Li X Onco Targets Ther; 2020; 13():3375-3387. PubMed ID: 32425545 [TBL] [Abstract][Full Text] [Related]
14. MnTE-2-PyP Attenuates TGF- Yang Y; Zhang P; Yan R; Wang Q; Fang E; Wu H; Li S; Tan H; Zhou X; Ma X; Tang Y; Huang Y; Deng R; Liu Y; Tong S; Wang Z; Oberley-Deegan RE; Tong Q Oxid Med Cell Longev; 2019; 2019():8639791. PubMed ID: 30931081 [TBL] [Abstract][Full Text] [Related]
15. Atractylenolide II inhibits tumor-associated macrophages (TAMs)-induced lung cancer cell metastasis. Zhang Y; Liu Y; Wang J; Jiang Z; Zhang L; Cui Y; Zhao D; Wang Y Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):227-237. PubMed ID: 35166628 [TBL] [Abstract][Full Text] [Related]
16. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
17. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells. Yang W; Gong X; Wang X; Huang C Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of SOCS2 Inhibits EMT and M2 Macrophage Polarization in Cervical Cancer Li D; Huang Y; Wei M; Chen B; Lu Y Comb Chem High Throughput Screen; 2024; 27(7):984-995. PubMed ID: 37594110 [TBL] [Abstract][Full Text] [Related]
19. Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling. Deswal B; Bagchi U; Kapoor S Anticancer Agents Med Chem; 2024; 24(2):146-156. PubMed ID: 37957871 [TBL] [Abstract][Full Text] [Related]
20. HMGB1 Positive Feedback Loop Between Cancer Cells and Tumor-Associated Macrophages Promotes Osteosarcoma Migration and Invasion. Hou C; Lu M; Lei Z; Dai S; Chen W; Du S; Jin Q; Zhou Z; Li H Lab Invest; 2023 May; 103(5):100054. PubMed ID: 36801636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]